Sciwind starts subject dosing with Ecnoglutide’s oral form in Phase I trial
The trial will assess XW004 at doses of up to 30mg administered daily in nearly 56 healthy subjects.

The trial will assess XW004 at doses of up to 30mg administered daily in nearly 56 healthy subjects.
Oncoshot enables data-driven cancer trials and expedites enrolment in ones that are actively recruiting participants.
The companies will address high costs for site activation and enrolment barriers linked to NASH drug trials.
Moderna could start a Phase I trial of its mRNA HIV vaccine as early as this week, according to a…
ByThe Defense Threat Reduction Agency (DTRA) in the US has awarded a new project agreement to Leidos to conduct clinical…
Cambridge Cognition, a provider of cognitive assessment software for clinical trials, has secured several new contracts to support pharmaceutical clients…
A research team at the University of Alabama at Birmingham (UAB) in the US has secured a contract to carry…
Clinical trial solutions provider Signant Health has agreed to provide electronic informed consent (eConsent) support for an oncology trial by…
Thank you for subscribing to Clinical Trials Arena